rs745814294
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_018297.4(NGLY1):c.930C>T(p.Gly310Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000547 in 1,461,656 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000055 ( 0 hom. )
Consequence
NGLY1
NM_018297.4 synonymous
NM_018297.4 synonymous
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 0.510
Genes affected
NGLY1 (HGNC:17646): (N-glycanase 1) This gene encodes an enzyme that catalyzes hydrolysis of an N(4)-(acetyl-beta-D-glucosaminyl) asparagine residue to N-acetyl-beta-D-glucosaminylamine and a peptide containing an aspartate residue. The encoded enzyme may play a role in the proteasome-mediated degradation of misfolded glycoproteins. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-25737407-G-A is Pathogenic according to our data. Variant chr3-25737407-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 221583.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, not_provided=1, Likely_pathogenic=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NGLY1 | NM_018297.4 | c.930C>T | p.Gly310Gly | synonymous_variant | 6/12 | ENST00000280700.10 | NP_060767.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NGLY1 | ENST00000280700.10 | c.930C>T | p.Gly310Gly | synonymous_variant | 6/12 | 1 | NM_018297.4 | ENSP00000280700.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 251018Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135656
GnomAD3 exomes
AF:
AC:
2
AN:
251018
Hom.:
AF XY:
AC XY:
1
AN XY:
135656
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461656Hom.: 0 Cov.: 30 AF XY: 0.00000825 AC XY: 6AN XY: 727142
GnomAD4 exome
AF:
AC:
8
AN:
1461656
Hom.:
Cov.:
30
AF XY:
AC XY:
6
AN XY:
727142
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Congenital disorder of deglycosylation Pathogenic:2Uncertain:1Other:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 25, 2024 | Variant summary: NGLY1 c.930C>T alters a conserved nucleotide resulting in a synonymous change. Several computational tools predict a significant impact on normal splicing: One predicts the variant strengthens a cryptic 3' acceptor site and two predict the variant creates this site. Publications report experimental evidence that this variant affects mRNA splicing (Wai_2020, Hirayama_2022). The variant allele was found at a frequency of 8e-06 in 251018 control chromosomes (gnomAD). c.930C>T has been reported in the literature in individuals affected with Congenital Disorder Of Deglycosylation who were compound heterozygous with a pathogenic variant (He_2015, Lam_2017). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function (Hirayama_2022). The compound heterozygous patients showed severely reduced NGLA1 activity compared to the parent who carried p.Gln208Ter, and no activity was detected using a recombinant protein that is expected to result from the splicing alteration. The following publications have been ascertained in the context of this evaluation (PMID: 25900930, 27388694, 32123317, 34939090). ClinVar contains an entry for this variant (Variation ID: 221583). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Pathogenic, no assertion criteria provided | clinical testing | Medical Biochemical Genetics, National Human Genome institute, NIH, National Institutes of Health | Jan 07, 2016 | - - |
not provided, no classification provided | literature only | GeneReviews | - | Splice site variant. Mild impairment - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 19, 2022 | This sequence change affects codon 310 of the NGLY1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the NGLY1 protein. RNA analysis indicates that this variant induces altered splicing and likely results in the loss of 25 amino acid residue(s), but is expected to preserve the integrity of the reading-frame. This variant is present in population databases (rs745814294, gnomAD 0.002%). This variant has been observed in individual(s) with NGLY1-related conditions (PMID: 25900930). ClinVar contains an entry for this variant (Variation ID: 221583). Studies have shown that this variant results in the activation of a cryptic splice site in exon 6 (PMID: 32123317). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at